Aclaris Therapeutics Inc (ACRS) — Financial Flexibility Index
Aclaris Therapeutics Inc (ACRS) has a Financial Flexibility Index of -0.20x as of September 2025. Free cash flow of $-10.91 Million (operating CF $-10.93 Million minus capex $23.00K) represents 0% of total liabilities ($55.43 Million). Check Aclaris Therapeutics Inc (ACRS) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aclaris Therapeutics Inc Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for Aclaris Therapeutics Inc across 12 annual periods. See working capital position of Aclaris Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Aclaris Therapeutics Inc (2013–2024)
Year-by-year free cash flow to debt coverage for Aclaris Therapeutics Inc. For the full company profile including market capitalisation, see Aclaris Therapeutics Inc (ACRS) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.31x | $-19.95 Million | $-20.07 Million | $64.77 Million | ▲ +83.9% |
| 2023 | -1.91x | $-77.02 Million | $-78.33 Million | $40.23 Million | ▼ -62.9% |
| 2022 | -1.18x | $-66.96 Million | $-67.57 Million | $56.98 Million | ▼ -22.2% |
| 2021 | -0.96x | $-51.83 Million | $-52.13 Million | $53.87 Million | ▲ +16.5% |
| 2020 | -1.15x | $-38.18 Million | $-38.63 Million | $33.13 Million | ▲ +65.5% |
| 2019 | -3.34x | $-94.83 Million | $-96.44 Million | $28.39 Million | ▼ -103.0% |
| 2018 | -1.65x | $-99.45 Million | $-100.81 Million | $60.44 Million | ▲ +43.8% |
| 2017 | -2.93x | $-53.43 Million | $-54.66 Million | $18.25 Million | ▲ +43.8% |
| 2016 | -5.21x | $-34.37 Million | $-34.60 Million | $6.59 Million | ▲ +59.2% |
| 2015 | -12.77x | $-19.86 Million | $-20.37 Million | $1.55 Million | ▼ -6646.9% |
| 2014 | -0.19x | $-7.22 Million | $-7.64 Million | $38.13 Million | ▲ +10.1% |
| 2013 | -0.21x | $-4.92 Million | $-4.92 Million | $23.37 Million | — |